$GILD Recent News Nasdaq slumps 1.2%, but Dow dips just

New Post Public Reply Private Reply Replies (0) Message Board

Mar 25, 2014 at 9:52 AM

$GILD Recent News

Nasdaq slumps 1.2%, but Dow dips just 0.2%: Stock market live blog recap 3:39 p.m. March 24, 2014 - blogs.marketwatch.com
Biotech has a second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - blogs.marketwatch.com
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - blogs.marketwatch.com
Newscast: Stocks close lower after late fade 4:26 p.m. March 21, 2014 - MarketWatch
First Solar extends winning streak; Symantec plunges 3:06 p.m. March 21, 2014 - Ben Eisen
Picking stocks to weather any market 1:15 p.m. March 21, 2014 - Mark Hulbert
The Nasdaq has a message to deliver 1:56 p.m. March 20, 2014 - The Trading Deck
Aeropostale slides; Liberty Media drops Sirius plan 4:15 p.m. March 14, 2014 - Saumya Vaishampayan
S&P 500 marks 50th record close; Nasdaq slips as biotechs reverse: Stock market live blog (recap) 4:38 p.m. March 6, 2014 - blogs.marketwatch.com
Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
When it comes to stocks, play follow the leader 3:54 p.m. Feb. 13, 2014 - The Trading Deck
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt

Biotech Sell-Off Brings Value To U.S. Healthcare Stocks 8:08 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: Stay Far Away From Boardwalk Partners 6:00 a.m. Today - TheStreet.com
Stick to Buying on Weakness Unless This Happens 9:58 p.m. March 24, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: The Enemy Is Us 8:14 p.m. March 24, 2014 - TheStreet.com
Trading Winds Blow Cold for Some Hot Stocks 7:17 p.m. March 24, 2014 - The Wall Street Journal Interactive Edition
U.S. Stocks Decline 7:03 p.m. March 24, 2014 - The Wall Street Journal Interactive Edition
Top Industry Groups Take Big Hits In Market Sell-Off 4:56 p.m. March 24, 2014 - Investors Business Daily
Gilead Down on Sovaldi Price Issue - Analyst Blog 4:45 p.m. March 24, 2014 - Zacks.com
Are Biotech Stocks Oversold? - Analyst Blog 4:26 p.m. March 24, 2014 - Zacks.com
Don't Hate Josh Brown For Calling Biotech a Bubble. Learn From Him. 4:17 p.m. March 24, 2014 - TheStreet.com
Dow Drops as Manufacturing Sector Shows Weakness, Nasdaq Slides as Biotechs Decline 4:14 p.m. March 24, 2014 - TheStreet.com
GILD, BIB, Others: How Worried Are Market-Makers About 'Government Pricing?' 3:14 p.m. March 24, 2014 - Seeking Alpha
3 ETFs Tumble Most on Biotech Sell-off - ETF News And Commentary 2:00 p.m. March 24, 2014 - Zacks.com
A Bubble Burst? Momentum Names Are Falling Hard 1:48 p.m. March 24, 2014 - Seeking Alpha
Sovaldi's Patent War 1:04 p.m. March 24, 2014 - Seeking Alpha
Breakthrough Therapy Status for Pfizer's Drug - Analyst Blog 11:30 a.m. March 24, 2014 - Zacks.com
Another Bad Day in Biotech Stocks, Pace of Selling Accelerates 11:21 a.m. March 24, 2014 - TheStreet.com
Weekly Insider Sells Highlight: KERX, ORCL, QCOM, GILD 11:06 a.m. March 24, 2014 - GuruFocus.com
Why Gilead Sciences (GILD) Shares Are Lower Today 10:55 a.m. March 24, 2014 - TheStreet.com
Weekly CFO Sells Highlight: Google Inc., Facebook Inc., Gilead Sciences Inc. ... 10:54 a.m. March 24, 2014 - GuruFocus.com

Janssen to Present New Simeprevir Data at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 8:00 a.m. March 24, 2014 - PR Newswire - PRF
Idenix Pharmaceuticals Intends to Appeal Norway District Court Decision Regarding Patent Invalidity Case 7:01 a.m. March 24, 2014 - GlobeNewswire
Gilead Sciences Prices Hepatitis C Drug at $84,000; Versartis Commences Trading on the NASDAQ 12:30 a.m. March 24, 2014 - ACCESSWIRE
AHF: Gilead’s ‘Obscene’ $180M Payday for CEO Fuels Shareholder Resolution on Compensation 4:57 p.m. March 17, 2014 - BusinessWire - BZX
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:03 a.m. March 14, 2014 - GlobeNewswire
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe 7:01 a.m. March 14, 2014 - Thomson Reuters ONE
Investor-Edge.com Most Active Equities Watch List: Staples, Gilead Sciences, Office Depot, and Sprint 8:00 a.m. March 7, 2014 - PR Newswire - PRF
Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo Fisher Scientific, HCA Holdings, and Nektar 8:25 a.m. March 6, 2014 - PR Newswire - PRF
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 9:31 a.m. March 5, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 6:15 p.m. March 4, 2014 - BusinessWire - BZX
Insider Trading Profile Alerts for Cisco, Gilead Sciences, Exxon Mobil, Facebook, Microsoft, and Bank of America 8:30 a.m. March 3, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 34th Cowen & Co. Healthcare Conference on Monday, March 3 5:00 p.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE
Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Insider Trading Update for Gilead Sciences, eBay, Walt Disney, Hewlett-Packard, Newmont Mining, and Apple 8:30 a.m. Feb. 24, 2014 - PR Newswire - PRF
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences 8:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kimley-Horn Shines as Top Workplace for Women Again

A Legacy of Workplace Excellence When you've been around the block as much as I have, you come to realize that standing out in the business world takes more than just numbers on a balance sheet—it takes heart, and maybe a bit of luck. That's why seeing Kimley-Horn bag the No. 13 spot on the Fortune Best Workplaces for Women list for the 10th time is something to raise...

Life Time's Q3 2026 Results Highlight Solid Growth

Life Time Rolls On With Strong Q3 Performance Sometimes the market hands you pure gold, and that's what Life Time (NYSE: LTH) has right now. They didn't just have a decent quarter; they outright nailed it with a $893.5 million total revenue haul—a hefty 14.2% rise from the prior year. What's driving this ship? Solid growth in membership dues and dynamic personal...

Read/Write Labs Tackles Brain-Tech Fusion Ambitions

Buck up, investors! There's a new player on the field marrying AI and neuroscience with some serious firepower and a respectable roster. Read/Write Labs—what you might've known yesterday as Dandelion Science—has kicked off under a fresh banner, amping up efforts to decode and recode our noggin's electrical orchestra. And with the likes of Jim DiCarlo, Dan Yamins, and...

Mausam Bhatt Joins Cars.com as Chief Product Officer

Shifting Gears with a New Leader Sometimes the name alone isn't enough to get things rolling, but when someone who's built billion-dollar platforms from scratch joins your team, the engine's ready to roar. That's the motor firing up at Cars.com with Mausam Bhatt behind the wheel as their fresh Chief Product Officer. If you think a new set of eyes can only see what's...

MetroScape: Local Roots Fuel Bold DFW Growth Plans

A Local Business with Big Aspirations Here's the deal, folks: Local guys Dr. Marc Nickell and Chris Brewer snatched up MetroScape Landscape like it was the last slice of grandma's pie. Why? Not just for the greenbacks—they're putting down roots in their very own backyard, the Dallas-Fort Worth area. What Does Local Really Mean? Look, it's one thing hitting up a...

ESI Motion's Role in Lockheed's Missile Defense Program

ESI Motion's Solar Drive Tech Joins the Defense Arena Picture this: ESI Motion Inc. just inked a deal with Lockheed Martin to supply Solar Array Drive Electronics (SADE) technology—a serious move in space tech. Now, ESI isn't just playing in the local Simi Valley sandbox; they're thrusting their tech into something much more critical—national defense. We're talking...

Faith on Trial: La Luz del Mundo Faces Court Ruling

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

CallRail's New Insight Tool: Navigating the Competitive Landscape

How CallRail's New Feature Changes the Game Ever sit in a boardroom meeting and wonder what your lead numbers really mean? CallRail just dropped a new feature that could change that. This AI-powered platform is now decking its 225,000 businesses with market insights to not just know their numbers but to understand how they stack up against their competition in the same...

Navigate360 Data Breach Concerns: Legal Insights

No Safety in a Storm: Navigate360's Data Breach Fiasco When you think of data breaches, you often envision some shady hacker in a hoodie, but here we are with Navigate360 losing control of a massive chunk of sensitive data involving school safety tips. You'd hope companies with serious access to personal information are better at keeping secrets, right? Yet, here we are,...

N? KOA's 11-Year Journey: From Art to Legacy

N? KOA: Leather Meets Polynesian Tattoo Art N? KOA, the Hawaii-based leather goods brand, knows a thing or two about weaving art into tradition. Eleven years back, they took the plunge with a compact line of men's bifold wallets, featuring designs by just three talented Polynesian tattoo artists. Today, that tribe's grown to 16 artists from across the Pacific, each...